Efficacy and Safety Study of TA-7284 in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of TA-7284 as monotherapy in
patients with type 2 Diabetes for 24 weeks administration.